Rural Health
Resources by Topic: Illicit drug use
Prescription Opioid Tapering Practices and Outcomes at a Rural VA Health Care System
Presents a study on the clinical characteristics of rural veterans using opioids for chronic pain and undergoing opioid tapering. Breaks down data on outcomes from tapering for rural veterans who were taking 90 Morphine Equivalent Daily Dose (MEDD) or more. Highlights common tapering outcomes, such as increased pain, suicidal ideation, and other withdrawal symptoms.
Author(s): Rena Elizabeth Courtney, Emily Halsey, Tanvi Patil, et al.
Citation: Pain Medicine, 25(7), 480-482
Date: 07/2024
Type: Document
view details
Presents a study on the clinical characteristics of rural veterans using opioids for chronic pain and undergoing opioid tapering. Breaks down data on outcomes from tapering for rural veterans who were taking 90 Morphine Equivalent Daily Dose (MEDD) or more. Highlights common tapering outcomes, such as increased pain, suicidal ideation, and other withdrawal symptoms.
Author(s): Rena Elizabeth Courtney, Emily Halsey, Tanvi Patil, et al.
Citation: Pain Medicine, 25(7), 480-482
Date: 07/2024
Type: Document
view details
Barriers to Healthcare and Social Service Utilization Among Rural Older Adults Who Use Drugs
Presents a study on the barriers to healthcare and social services access for older adults in rural communities who use drugs. Bases findings on survey results from rural adults over 50 who use drugs on perceived barriers to service utilization. Highlights how barriers such as a lack of transportation, health insurance, and permanent housing correlates with age.
Author(s): Beth Prusaczyk, Sandra Tilmon, Joshua Landman, et al.
Citation: Journal of Applied Gerontology, 43(12), 1977-1984
Date: 06/2024
Type: Document
view details
Presents a study on the barriers to healthcare and social services access for older adults in rural communities who use drugs. Bases findings on survey results from rural adults over 50 who use drugs on perceived barriers to service utilization. Highlights how barriers such as a lack of transportation, health insurance, and permanent housing correlates with age.
Author(s): Beth Prusaczyk, Sandra Tilmon, Joshua Landman, et al.
Citation: Journal of Applied Gerontology, 43(12), 1977-1984
Date: 06/2024
Type: Document
view details
Community Buprenorphine Continuation Post-Release Following Extended Release Vs. Sublingual Buprenorphine During Incarceration: A Pilot Project in Maine
Compares post-release outcomes among incarcerated people who received extended-release buprenorphine (XRB) versus sublingual buprenorphine (SLB) for opioid use disorder (OUD) in rural Maine jails. Includes data from two jails, one of which had implemented an XRB pilot program, on rates of post-release community buprenorphine treatment continuation, diversion, safety concerns, XRB side effects, and post-release mortality.
Author(s): Alane B. O'Connor, Catherine Gelsinger, Sadie M. Donovan, Jessica Marshall, Katherine A. Ahrens
Citation: Health & Justice, 12, 28
Date: 06/2024
Type: Document
view details
Compares post-release outcomes among incarcerated people who received extended-release buprenorphine (XRB) versus sublingual buprenorphine (SLB) for opioid use disorder (OUD) in rural Maine jails. Includes data from two jails, one of which had implemented an XRB pilot program, on rates of post-release community buprenorphine treatment continuation, diversion, safety concerns, XRB side effects, and post-release mortality.
Author(s): Alane B. O'Connor, Catherine Gelsinger, Sadie M. Donovan, Jessica Marshall, Katherine A. Ahrens
Citation: Health & Justice, 12, 28
Date: 06/2024
Type: Document
view details
Treatment for Opioid Use Disorder: Population Estimates — United States, 2022
Describes the U.S. adult populations who need opioid use disorder (OUD) treatment, receive any OUD treatment, and receive medication for OUD. Includes data for metropolitan compared to micropolitan and noncore locations.
Author(s): Deborah Dowell, Samantha Brown, Shiromani Gyawali, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 73(25), 567-574
Date: 06/2024
Type: Document
Sponsoring organization: Centers for Disease Control and Prevention
view details
Describes the U.S. adult populations who need opioid use disorder (OUD) treatment, receive any OUD treatment, and receive medication for OUD. Includes data for metropolitan compared to micropolitan and noncore locations.
Author(s): Deborah Dowell, Samantha Brown, Shiromani Gyawali, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 73(25), 567-574
Date: 06/2024
Type: Document
Sponsoring organization: Centers for Disease Control and Prevention
view details
Is Peer Support a Tipping Point for the Opioid Use Disorder Crisis in Appalachia? Research Holds the Answer
Investigates how the relationship among cultural, socioeconomic, medical, and geographic factors in Central Appalachia create additional burdens for opioid use recovery. Analyzes the effectiveness of medications for opioid use disorder and peer recovery support services, providing recommendations to address opioid use disorder in Appalachia.
Author(s): Kimberly Horn, Stephanie M. Mathis, Lara Nagle, et al.
Citation: Harm Reduction, 21, 122
Date: 06/2024
Type: Document
view details
Investigates how the relationship among cultural, socioeconomic, medical, and geographic factors in Central Appalachia create additional burdens for opioid use recovery. Analyzes the effectiveness of medications for opioid use disorder and peer recovery support services, providing recommendations to address opioid use disorder in Appalachia.
Author(s): Kimberly Horn, Stephanie M. Mathis, Lara Nagle, et al.
Citation: Harm Reduction, 21, 122
Date: 06/2024
Type: Document
view details
Attitudes Toward and Training in Medications for Opioid Use Disorders: A Descriptive Analysis among Employees in the Youth Legal System and Community Mental Health Centers
Results of a survey of 181 medications for opioid use disorder uptake (MOUD) professionals who work with youth legal system (YLS) and community mental health center (CMHC) settings in eight counties of a Midwestern state. Compares attitudes toward MOUD treatment, training, and workplace culture in rural versus urban areas, among CMHC versus YLS respondents, and more.
Author(s): Lauren M. O'Reilly, Katherine Schwartz, Steven A. Brown, et al.
Citation: Substance Abuse Treatment, Prevention, and Policy, 19, 32
Date: 06/2024
Type: Document
view details
Results of a survey of 181 medications for opioid use disorder uptake (MOUD) professionals who work with youth legal system (YLS) and community mental health center (CMHC) settings in eight counties of a Midwestern state. Compares attitudes toward MOUD treatment, training, and workplace culture in rural versus urban areas, among CMHC versus YLS respondents, and more.
Author(s): Lauren M. O'Reilly, Katherine Schwartz, Steven A. Brown, et al.
Citation: Substance Abuse Treatment, Prevention, and Policy, 19, 32
Date: 06/2024
Type: Document
view details
Facilitators and Barriers to Adopting or Expanding Medications for Opioid Use Disorder Provision in Rural Colorado Jails: a Qualitative Analysis
Reports findings of interviews with representatives of 7 rural Colorado jails on facilitators and barriers of medication for opioid use disorder (MOUD) adoption and expansion. Discusses factors including attitudes toward MOUD, collaborative partnerships, physical space, distance to services, provider availability, staff, and more.
Author(s): Heidi L. McNeely, Terri L. Schreiber, William L. Swann, Claudia R. Amura
Citation: Health and Justice, 12, 26
Date: 06/2024
Type: Document
view details
Reports findings of interviews with representatives of 7 rural Colorado jails on facilitators and barriers of medication for opioid use disorder (MOUD) adoption and expansion. Discusses factors including attitudes toward MOUD, collaborative partnerships, physical space, distance to services, provider availability, staff, and more.
Author(s): Heidi L. McNeely, Terri L. Schreiber, William L. Swann, Claudia R. Amura
Citation: Health and Justice, 12, 26
Date: 06/2024
Type: Document
view details
Evaluation of the Maternal Opioid Misuse (MOM) Model: Third Annual Report (Implementation Year 2)
Provides an overview of the Maternal Opioid Misuse Model, which provides evidence-based integrated care and care coordination for pregnant and postpartum Medicaid beneficiaries with opioid use disorder (OUD). Describes activities MOM Model awardees undertook during the MOM Model's second implementation year, July 1, 2022–June 30, 2023. Discusses barriers pregnant and postpartum people with OUD face in accessing high-quality, continuous care, specifically in rural areas.
Additional links: Findings at a Glance
Date: 05/2024
Type: Document
Sponsoring organizations: Centers for Medicare and Medicaid Services, Insight Policy Research
view details
Provides an overview of the Maternal Opioid Misuse Model, which provides evidence-based integrated care and care coordination for pregnant and postpartum Medicaid beneficiaries with opioid use disorder (OUD). Describes activities MOM Model awardees undertook during the MOM Model's second implementation year, July 1, 2022–June 30, 2023. Discusses barriers pregnant and postpartum people with OUD face in accessing high-quality, continuous care, specifically in rural areas.
Additional links: Findings at a Glance
Date: 05/2024
Type: Document
Sponsoring organizations: Centers for Medicare and Medicaid Services, Insight Policy Research
view details
Health Disparities in Tennessee
Examines health disparities experienced by Tennessee residents. Measures include life expectancy, health equity, healthcare access, mental health and trauma, infectious disease, chronic disease, cancer, reproductive health, and age-specific health. Features statistics with breakdowns by race, ethnicity, gender, and urban or rural location.
Date: 05/2024
Type: Document
Sponsoring organization: Tennessee Department of Health
view details
Examines health disparities experienced by Tennessee residents. Measures include life expectancy, health equity, healthcare access, mental health and trauma, infectious disease, chronic disease, cancer, reproductive health, and age-specific health. Features statistics with breakdowns by race, ethnicity, gender, and urban or rural location.
Date: 05/2024
Type: Document
Sponsoring organization: Tennessee Department of Health
view details
Evaluation of Using Telehealth for Opioid Use Disorders in a Correctional Setting
Report evaluates a telehealth intervention in a rural county jail to provide medications for opioid use disorder (MOUD) and therapy to inmates with opioid use disorder (OUD) during the COVID-19 pandemic. Highlights program goals and details data from participant surveys on the intervention's perceived quality and efficacy.
Author(s): Marina Duane, Jennifer Yahner, Malore Dusenbery, Erica Henderson
Date: 05/2024
Type: Document
Sponsoring organizations: National Criminal Justice Reference Service, Office of Justice Programs
view details
Report evaluates a telehealth intervention in a rural county jail to provide medications for opioid use disorder (MOUD) and therapy to inmates with opioid use disorder (OUD) during the COVID-19 pandemic. Highlights program goals and details data from participant surveys on the intervention's perceived quality and efficacy.
Author(s): Marina Duane, Jennifer Yahner, Malore Dusenbery, Erica Henderson
Date: 05/2024
Type: Document
Sponsoring organizations: National Criminal Justice Reference Service, Office of Justice Programs
view details